Category Archives: Birth Defects

Featured Stories

First Bard Avaulta Transvaginal Mesh Lawsuit Scheduled for February Trial in MDL

The first test trials in the federal C.R. Bard Avaulta transvaginal mesh litigation will most likely start next year, according to a report from Bloomberg News. About 600 lawsuits involving Bard Avaulta transvaginal mesh products are currently pending in the multidistrict litigation underway Charleston, West Virginia. U.S. District Judge Joseph ...

Read More

Smith & Nephew Says Metal-on-Metal Hip Replacement Controversy Slowing Sales of Birmingham Hip Resurfacing System

Medical device maker Smith & Nephew has reported a drop in sales of its metal-on-metal hip implant devices. According to the company, hip implant sales were down 2 percent during the first quarter of 2012, largely because its Birmingham Hip Resurfacing System suffered from an association with other metal-on-metal hip ...

Read More

Boston Scientific Transvaginal Mesh

Tennessee Woman Alleges Boston Scientific Transvaginal Mesh Product Caused Painful Injuries

More reports of painful injuries are being linked to transvaginal mesh. This time, a Tennessee woman has filed a lawsuit against Boston Scientific over its Advantage Transvaginal Mid-Urethral Sling System.

Read More

Older Patients Face Heart Attack Risk Following Surgery

Older Hip Implant, Knee Replacement Patients Face Heart Attack Risk Following Surgery

An emerging report reveals that older hip implant and knee replacement patients face increased heart attack risks following surgery. The risk for acute myocardial infarction (AMI) was seen in the first two weeks after these surgical procedures.

Read More

1,000+ Australians Join DePuy ASR Hip Implant Class Action Lawsuit

A class action lawsuit filed in Australia over DePuy Orthopaedics’ recalled metal-on-metal ASR Hip Implants has signed up more than 1,000 plaintiffs. The attorneys representing the Australian ASR Hip Implant lawsuit plaintiffs recently told The Courier-Mail that damages in the lawsuit are expected to be worth more than $200 million. One ...

Read More

Stryker Issues Voluntary Recall for Rejuvenate Modular and ABG II Hip Implant Components

Stryker Orthopedics is recalling two metal-on-metal hip implant components, its Rejuvenate Modular and ABG II modular-neck hip stems. According to a notice posted on Stryker’s website, risks associated with the Rejuvenate Modular and ABG II modular-neck hip stems include the potential for fretting and/or corrosion at or about ...

Read More

Failing DePuy ASR Hip Implants Sending Hundreds of Australians Back to the OR

Roughly 1,000 people in Australia have had to undergo revision surgeries because of failed DePuy ASR hip implants. According to TheAge.com, DePuy Orthopaedics has heard from more than 4,000 people in Australia and New Zealand seeking help with the recalled metal-on-metal hip replacement devices.

Read More

Metal-on-Metal Hip Replacement Concerns Grow in Canada

Canadian patients and doctors are voicing more concerns about metal-on-metal hip replacements, as health regulators around the world continue to investigate the safety of the devices. According to a report from the CBC, four companies have recently either recalled or suspended sales of metal-on-metal hip replacement devices, while a number ...

Read More

Parker Waichman Representing Another Louisiana Plaintiff in Actos Bladder Cancer Lawsuit

A Louisiana man has become the latest to claim that his taking the type 2 diabetes drug Actos resulted in developing bladder cancer. He has filed a lawsuit against the Japanese manufacturer of the drug and the marketer of it in the U.S., claiming they failed to warn about this ...

Read More

Metal-on-Metal Hip Implant Lawyer Takes Issue with Statements Made by DePuy Orthpaedics Official During FDA Meeting

An attorney with a national law firm that represents victims of alleged metal-on-metal hip implant injuries has expressed dismay at some statements made last week regarding the regulation of all-metal hip replacement devices by an official with DePuy Orthopaedics. According to Daniel Burke, Senior Litigation Counsel at Parker ...

Read More

Exposure to 9/11 Toxic Cloud Linked to Low Birth Weight Babies

Fifteen years after the collapse of the World Trade Center towers in the September 11, 2001 terrorist attack, researchers are still learning the impact of the attacks on people’s health. When the twin towers fell, a cloud of toxic dust … Continue reading

Posted in Birth Defects, Health Concerns, Toxic Substances |

New Jersey Mother Blames Zofran for Daughter’s Birth Defects

A woman alleges her daughter, born in 2007, is a victim of her having taken Zofran during her first trimester of pregnancy. The anti-nausea drug is a treatment for chemotherapy patients, radiation patients, and patients’ recovering from the effects of … Continue reading

Posted in Birth Defects, Health Concerns, Legal News, Pharmaceuticals |

Zofran Birth Defect Lawsuit Update: “Sequence Discovery” Issue

Zofran Birth Defect Case Update: “Sequence Discovery” Issue

Plaintiffs in more than 200 birth defect lawsuits have raised concerns over the pharmaceutical company GlaxoSmithKline’s (GSK) new proposal for Sequenced Discovery. Parents say the company neglected to warn patients and health experts of its anti-nausea drug Zofran’s alleged potential … Continue reading

Posted in Birth Defects, Health Concerns, Pharmaceuticals | Tagged , , , , , |

Using Short Form Complaint, New Zofran Lawsuit Filed in Massachusetts Court

There will be a new way to file Zofran lawsuits that claim the pharmaceutical giant GlaxoSmithKline’s anti-nausea drug Zofran can cause birth defects. More than 260 families claim that GlaxoSmithKline (GSK) failed to warn them of Zofran’s alleged risks, in … Continue reading

Posted in Birth Defects, Health Concerns, Legal News, Pharmaceuticals |

Zofran Birth Defects Litigation Moves Forward

In the federal multidistrict litigation (MDL) presently underway in the U.S. District Court, District of Massachusetts, more than 260 Zofran birth defect lawsuits continue to move forward. The parties involved have jointly submitted proposed Master Long Form and Short Form … Continue reading

Posted in Birth Defects, Health Concerns, Legal News, Pharmaceuticals |

Study Shows Lyrica Linked to Major Birth Defects

New research has linked the medication Lyrica with birth defects in the babies of pregnant woman who take the drug. Lyrica (pregabalin) is prescribed to treat seizures, neuropathic pain, fibromyalgia, anxiety disorders, psychiatric conditions, and restless leg syndrome. But there … Continue reading

Posted in Birth Defects, Health Concerns, Pharmaceuticals |

Risk of Major Birth Defects when Lyrica is taken during Pregnancy

Lyrica (pregabalin) is used to treat diabetic nerve pain, fibromyalgia, epilepsy, post-herpetic neuraligia caused by shingles and spinal cord injury. It is also prescribed “off label”, meaning it is approved by the U.S. Food and Drug Administraton (FDA), but specified … Continue reading

Posted in Birth Defects, Health Concerns, Pharmaceuticals |

Scientists Call for Fresh Look at Dangers of Glyphosate Herbicides

A group of health scientists worried about the explosive growth of agricultural chemicals’ use worldwide is pressing U.S. and European health officials to examine the health impacts of glyphosate herbicides. A report published on February 17, 2016 in Environmental Health, … Continue reading

Posted in Birth Defects, Health Concerns, Toxic Substances |

Judge Denies GlaxoSmithKline Motion to Dismiss Birth Defect Claims in Zofran Litigation

On January 22, 2016, a federal judge in Massachusetts denied GlaxoSmithKline’s motion to dismiss all claims in multidistrict litigation alleging that the drug company’s off-label promotion of its anti-nausea drug Zofran (ondansetron) for morning sickness led to birth defects. U.S. District … Continue reading

Posted in Birth Defects, Health Concerns, Pharmaceuticals |

Federal Judge Denies Motion to Dismiss Claims in Zofran Birth Defect Cases

zofran-baby

A federal judge in Massachusetts has denied a motion by drug maker GlaxoSmithKline to dismiss cases alleging that the drug Zofran (ondansetron) caused birth defects on the grounds that federal law preempts state failure-to-warn claims. Federal law is the “supreme” … Continue reading

Posted in Birth Defects, Defective Products, Health Concerns, Legal News, Pharmaceuticals | Tagged , , , , |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.